Serum Market Set To Grow From $1.72 Billion In 2026 To $2.55 Billion By 2030 At A CAGR Of 10.4%
Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Serum Market Forecast Highlighting Growth From $1.72 Billion To $2.55 Billion
The serum market has experienced rapid expansion in recent years. It is projected to increase from $1.56 billion in 2025 to $1.72 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.5%. Historically, this growth has been driven by factors such as rising funding for academic research, the broader adoption of cell culture methods, heightened usage of bovine serum in laboratory settings, a higher volume of diagnostic tests, and the initial development of biopharmaceutical manufacturing.
The serum market is projected to experience substantial expansion in the coming years, reaching a value of $2.56 billion by 2030, driven by a compound annual growth rate (CAGR) of 10.4%. This growth trajectory during the forecast period is fueled by factors such as a surge in vaccine and biologics production, a growing embrace of precision medicine, the widening scope of cell-based research pipelines, an elevated need for high-purity serum grades, and an overall enhancement in global biopharmaceutical manufacturing capacity. Key developments anticipated in this period encompass a heightened demand for serum within cell culture media, a movement towards standardization of serum quality, a broadening application of heat-inactivated serum products, the expansion of serum utilization in vaccine development, and an increased preference for serum sources that are fully traceable and certified.
Download A Free Sample Report For Comprehensive Market Insights:
Serum Market Growth Factors Supporting Long-Term Expansion
The growing awareness surrounding skin conditions linked to aging is set to drive the expansion of the serum market in the coming period. These age-related skin issues encompass common problems experienced by older individuals, like wrinkles and facial expression lines. Serums are designed to address such concerns, including dullness, hyperpigmentation, dehydration, and loss of firmness, while also helping to even skin tone, brighten it, reduce visible imperfections, and nourish the skin. For example, Cancer Australia, a government agency based in Australia, reported in 2023 that roughly 8,257 new melanoma cases related to skin cancer were identified, representing 2.6% of all cancer-related deaths. As a result, the increasing focus on age-related skin conditions is fueling market growth for serums.
Serum Market Segment Breakdown: Which Categories Generate The Most Revenue?
The serum market covered in this report is segmented –
1) By Type: Bovine Serum, Fetal bovine serum (FBS), Other Types
2) By Inactivation Technique: Heat Inactivated, Non-Heat Inactivated
3) By Application: Biological Products, Research, Cell Culture, Biopharmaceutical Drugs, Vaccine Products, Diagnostic Products, Other Applications
Subsegments:
1) By Bovine Serum: Raw Bovine Serum, Processed Bovine Serum, Fetal Bovine Serum (FBS)
2) By Fetal Bovine Serum (FBS): FBS (Heat-Inactivated), FBS (Non-Heat-Inactivated)
3) By Other Types: Equine Serum, Porcine Serum, Human Serum
Serum Market Industry Trends Shaping Future Revenue Growth
Leading enterprises in the serum sector are concentrating on developing innovative offerings, such as ultrasensitive biomarker detection, to secure a market advantage. This detection method refers to the capacity to identify and quantify biomarkers at very low levels, facilitating earlier disease diagnosis. For example, in July 2023, Quanterix, a US firm specializing in digital biomarker analysis, introduced the LucentAD Biomarker Blood Test. This assay measures a specific phosphorylated tau protein isoform in plasma, designed to assist medical professionals in diagnosing Alzheimer’s disease. The test relies on a serum sample, and its findings are interpreted alongside additional diagnostic procedures. By enhancing both the precision and efficiency of Alzheimer’s identification, this solution ultimately benefits patients and the healthcare system alike.
Serum Market Key Players And Strategic Industry Positioning
Major companies operating in the serum market are Merck Group, Thermo Fisher Scientific Inc., Danaher Corp, Corning Incorporated, Sartorius AG, Bio-Techne Corporation, Takara Bio Inc., Atlas Biologicals Inc., Proliant Health & Biologicals, Seracare Life Sciences Inc., Lampire Biological Labs Inc., Altogen Labs, Innovative Research Inc., Lee Biosolutions Inc., Bovogen Biologicals Pty. Ltd., Caisson Labs Inc., Gemini BioProducts Holding Inc., Valley Biomedical Products & Services Inc., Equitech-Bio Inc., Rocky Mountain Biologicals, PAN-Biotech GmbH, BIOWEST SAS, Moregate Biotech, Tissue Culture Biologicals, Kerafast Inc., Access Biologicals LLC, Animal Technologies Inc., Cell Applications Inc., Cell Sciences Inc.
Access The Complete Serum Market Report:
Serum Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the serum market in 2025. The regions covered in the serum market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
